MAAT INDEX

CLAIM #48627 · Pfizer Inc (PFE) · 2025Q3 earnings call · Nov 4, 2025 · due Dec 31, 2025

We remain on track to deliver on our goal of at least $4.5 billion in cumulative net cost savings from our ongoing cost realignment program by the end of this year.

David Denton · CFO

PENDING
graded after results covering Dec 31, 2025 are reported

Verify independently

SEC filings for PFE · Claim quote is verbatim from the 2025Q3 earnings call.